Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-29

Clinical Trial Update: Study of LY2409021 in Participants With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for LY2409021 in participants with Type 1 diabetes; study completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY2409021

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2018-10-29